Sankey It
Loading...
Eli Lilly and Company Q1 FY2026 income statement | Sankey It
Sankey It · LLY
Eli Lilly and Company Q1 FY2026 income statement
USD · quarter ended 2026-03-31
Q2 FY2026
Q1 FY2026
Q4 FY2025
Q3 FY2025
Q2 FY2025
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Eli Lilly and Company Q1 FY2026 income statement
Flow diagram with 7 nodes and 6 flows for Eli Lilly and Company Q1 FY2026 income statement. Values: Revenue US$19.8B, Cost of Revenue US$3.6B, Gross Profit US$16.2B, Operating Expenses US$7.4B, Operating Income US$8.9B, Tax US$1.5B, Net Income US$7.4B.
Revenue
US$19.8B
Cost of Revenue
(US$3.6B)
18% of revenue
Gross Profit
US$16.2B
82% margin
Operating Expenses
(US$7.4B)
37% of revenue
Operating Income
US$8.9B
45% margin
Tax
(US$1.5B)
7% of revenue
Net Income
US$7.4B
37% margin
Net / profit
Tax / cost
Copy link
Share on X
Open full screen